Search

Search Constraints

You searched for: Author/Creator Streetly, Matthew

Search Results

1. Bone Marrow Assessment in Asymptomatic IgM Monoclonal Gammopathies – Reply to Varettoni et al. (27th August 2014)

2. Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial. Issue 12 (December 2016)

4. COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial. (21st November 2020)

5. Extended follow‐up and the feasibility of Panobinostat maintenance for patients with Relapsed Multiple Myeloma treated with Bortezomib, Thalidomide, Dexamethasone plus Panobinostat (MUK six open label, multi‐centre phase I/II Clinical Trial). (20th August 2018)

7. Guidelines on the diagnosis and management of Waldenström macroglobulinaemia. (15th February 2014)

10. Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial. (11th October 2021)